OncoMatch/Clinical Trials/NCT04980716
Early Specialized Cardiovascular Intervention Based on Impedance Cardiography in Locally Advanced Non-small Cell Lung Cancer Patients
Is NCT04980716 recruiting? Yes, currently enrolling (Jun 2026). This Phase 3 trial studies Multiple cardiovascular drugs related to "Golden Triangle" for non-small cell lung cancer.
Treatment: Multiple cardiovascular drugs related to "Golden Triangle" — This is a prospective, randomized, controlled, multi-center phase III clinical trial that intends to evaluate the role of early cardiovascular intervention based on impedance cardiography in patients with locally advanced non-small cell lung cancer receiving radical radiochemotherapy±immunotherapy.
Check if I qualifyExtracted eligibility criteria
Treatments studied
Other
Cancer type
Non-Small Cell Lung Carcinoma
Disease stage
Required: Stage III
Performance status
WHO 0–1
Demographics
Lab requirements
Blood counts
absolute neutrophil count ≥1.5×10^9/L; platelets ≥100×10^9/L; hemoglobin ≥90 g/L
Kidney function
serum creatinine clearance calculated according to the Cockcroft-Gault formula ≥50 mL/min
Liver function
serum bilirubin ≤1.5 times ULN; alanine aminotransferase and aspartate aminotransferase ≤2.5 times ULN
Cardiac function
FEV1 ≥1000 ml
Organ and bone marrow function meet the following conditions: Forced expiratory volume per second (FEV1) ≥1000 ml; absolute neutrophil count ≥1.5×10^9/L; platelets ≥100×10^9/L; hemoglobin ≥90 g/L ; Serum creatinine clearance calculated according to the Cockcroft-Gault formula ≥50 mL/min (Cockcroft and Gault 1976); serum bilirubin ≤1.5 times the upper limit of normal (ULN); alanine aminotransferase and aspartate aminotransferase ≤2.5 times ULN
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT04980716 currently recruiting?
Yes, this trial is currently recruiting patients.
What disease stage is eligible?
Stage III is required.
Is there an age limit?
Yes. Patients must be 75 years or younger.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages